Federal Register / Vol. 60, No. 97 / Friday, May 19, 1995 / Notices 26891

Washington, DC 20402–9325, telephone

(202) 512–1800.

Dated: May 15, 1995.

Diane D. Porter,

Acting Director, National Institute for

Occupational Safety and Health, Centers for

Disease Control and Prevention (CDC).

References

1. U.S. General Accounting Office, (1991).

Child Labor: Characteristics of Working

Children. Publication No. GAO/HRD–

91–83BR. Washington, D.C.: Author.

2. Castillo KN, Landen DD, Layne LA, (1994).

Occupational injury deaths of 16- and

17-year olds in the United States.

American Journal of Public Health 19:

739–45.

3. Layne LA, Castillo DN, Stout N, Cutlip P,

(1994). Adolescent occupational injuries

requiring hospital emergency department

data. American Journal of Public Health.

84–4: 657–660.

4. Centers for Disease Control, (1983)

Surveillance of occupational injuries

treated in hospital emergency rooms—

United States, 1982. Morbidity and

Mortality Weekly Report 32 (2SS): 713–

716.

5. Knight EB, Castillo DN, Layne LA (in

press). A detailed analysis of workrelated injury among youth treated in

emergency departments. American

Journal of Industrial Medicine.

6. Bush D, Baker, R (1994). Young Workers

at Risk: Health and Safety Education and

the Schools. Berkeley, CA: Labor

Occupational Health Program.

7. Borman KM, Izzo MV, Penn E, Reisman J,

(1984). The Adolescent Worker.

Columbus, OH: National Center for

Research in Vocational Education.

8. Jackson C, Fortmann SP, Flora JA, Melton

RJ, Snider JP, Littlefield D, (1994) The

capacity-building approach to

intervention maintenance implemented

by the Stanford Five-City Project, Health

Education Research, 9, 3:385–396.

9. Rogers EM, Shoemaker F (1973).

Communication of Innovations. New

York: Free Press.

[FR Doc. 95–12325 Filed 5–18–95; 8:45 am]

BILLING CODE 4163–19–P

Hospital Infection Control Practices

Advisory Committee: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting.

Name: Hospital Infection Control Practices

Advisory Committee.

Times and Dates: 8:30 a.m.–5 p.m., June

12, 1995. 8:30 a.m.–4 p.m., June 13, 1995.

Place: CDC, Auditorium A, 1600 Clifton

Road, NE, Atlanta, Georgia 30333.

Status: Open to the public, limited only by

the space available.

Purpose: The committee is charged with

providing advice and guidance to the

Secretary, the Assistant Secretary for Health,

the Director, CDC, and the Director, National

Center for Infectious Diseases (NCID),

regarding the practice of hospital infection

control and strategies for surveillance,

prevention, and control of nosocomial

infections in U.S. hospitals and updating of

guidelines and other policy statements

regarding prevention of nosocomial

infections.

Matters to be Discussed: The agenda will

include review and discussion of public

comments regarding the draft Guideline for

Isolation Precautions in Hospitals, review of

the status of the draft Guideline for the

Prevention of Nosocomial Intravascular

Device-Related Infections, review of the

status of the proposed first draft of the

Guideline for Infection Control in Hospital

Personnel, and an update on CDC activities

of interest to the committee. Agenda items

are subject to change as priorities dictate.

Contract Person for More Information:

Marsha A. Jones, Associate Director for

Management, Hospital Infections Programs,

NCID, CDC, 1600 Clifton Road, NE, Mailstop

A–07, Atlanta, Georgia 30333, telephone 404/

639–6402.

Dated: May 12, 1995.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 94–12326 Filed 5–18–95; 8:45 am]

BILLING CODE 4163–18–M

National Committee on Vital and Health

Statistics: Meeting

Pursuant to Pub. L. 92–463, the

National Center for Health Statistics

(NCHS), Centers for Disease Control and

Prevention (CDC), announces the

following committee meeting.

Name: National Committee on Vital and

Health Statistics (NCVHS).

Times and Dates: 1 p.m.–5 p.m., June 14,

1995. 9 a.m.–5 p.m., June 15, 1995. 9 a.m.–

3 p.m., June 16, 1995.

Place: Room 703A, Hubert H. Humphrey

Building, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open.

Purpose: The purpose of this meeting is for

the committee to consider reports from each

NCVHS subcommittee; to receive reports

from offices of the Department of Health and

Human Services; to receive a report from the

Center for Health Policy Studies on a

working compendium of core health data sets

currently in use or proposed for use for

person level and event level in the United

States; to discuss the Unified Medical

Language System developed by the National

Library of Medicine; and to address new

business as appropriate.

Contact Person for More Information:

Substantive program information as well as

summaries of the meeting an a roster of

committee members may be obtained from

Gail F. Fisher, Ph.D, Executive Secretary,

NCVHS, NCHS, CDC, Room 1100,

Presidential Building, 6525 Belcrest Road,

Hyattsville, Maryland 20782, telephone 301/

436–7050.

Dated: May 12, 1995.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 94–12327 Filed 5–18–94; 8:45 am]

BILLING CODE 4163–18–M

Food and Drug Administration

[Docket No. 94F–0431]

Asahi Chemical Industry Co., Ltd.;

Filing of Food Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Asahi Chemical Industry Co., Ltd.,

has filed a petition proposing that the

food additive regulations be amended to

provide for the safe use of two grades of

dimethylpolysiloxane with viscosities of

100 centistokes and 50 centistokes,

intended for use as release agents in the

manufacture of thermoplastic

elastomers.

DATES: Written comments on the

petitioner’s environmental assessment

by June 19, 1995.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, rm. 1–23, 12420

Parklawn Dr., Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Julius Smith, Center for Food Safety and

Applied Nutrition (HFS–216), Food and

Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3091.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a petition (FAP

3B4396) has been filed by Asahi

Chemical Industry Co., Ltd., HibiyaMitsui Bldg., 1–2, Yuraku-cho 1–

Chome, Chiyoda-ku, Tokyo, T100,

Japan. The petition proposes to amend

the food additive regulations to provide

for the safe use of two grades of

dimethylpolysiloxane with viscosities of

100 centistokes and 50 centistokes,

intended for use as release agents in the

manufacture of thermoplastic

elastomers.

The potential environmental impact

of this action is being reviewed. To

encourage public participation

consistent with regulations promulgated

under the National Environmental

Policy Act (40 CFR 1501.4(b)), the

agency is placing the environmental